Alterations in responses to LSD in humans associated with chronic administration of tricyclic antidepressants, monoamine oxidase inhibitors or lithium.

Behav Brain Res 1996 DOI: 10.1016/0166-4328(96)00102-7 (opens in new tab)

Study at a glance

AI-extracted from the abstract

Characteristics	Peer reviewed
Topics	LSD

Abstract

Alterations in responses to LSD in humans associated with chronic administration of tricyclic antidepressants, monoamine oxidase inhibitors or lithium.

Chronic administration of serotonergic antidepressants attenuates the subjective effects of LSD in humans. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology June 1996
Behavioral sensitivity to LSD: Dependency upon the pattern of central 5HT depletion Pharmacology Biochemistry and Behavior May 1, 1977 18 citations
Chronic treatment with LY341495 decreases 5-HT2A receptor binding and hallucinogenic effects of LSD in mice Neuroscience Letters January 16, 2013 44 citations
Enhancing action of LSD on neuronal responsiveness to serotonin in a brain structure involved in obsessive–compulsive disorder The International Journal of Neuropsychopharmacology March 1, 2003 13 citations
Changes in global and thalamic brain connectivity in LSD-induced altered states of consciousness are attributable to the 5-HT2A receptor Elife October 25, 2018 416 citations

Study at a glance

Abstract

Related reading